ZBNA
CORT icon

Zions Bancorporation, National Association’s Corcept Therapeutics CORT Stock Holding History

Zions Bancorporation, National Association’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.61K Buy
30
+1
+3% +$60 ﹤0.01% 1238
2026
Q1 		$1.17K Buy
+29
New +$1.08K ﹤0.01% 1317

Other funds holding CORT

BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.92B AUM 26.86% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.79B AUM 30.56% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

Zions Bancorporation, National Association's CORT Position: Q2 2026 in Review

Zions Bancorporation, National Association increased its Corcept Therapeutics (CORT) stake by 3.4% in Q2 2026, buying an estimated $60 and bringing the position to 30 shares worth $2.61K. The position accounts for ﹤0.01% of the portfolio, ranked #1238.

Zions Bancorporation, National Association first reported a position in CORT in Q1 2026 and has held it in 2 quarters since. 113 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Zions Bancorporation, National Association held 30 shares of Corcept Therapeutics worth $2.61K as of Q2 2026.
  • Zions Bancorporation, National Association bought 1 Corcept Therapeutics share in Q2 2026, an estimated $60.
  • Corcept Therapeutics made up ﹤0.01% of Zions Bancorporation, National Association's portfolio in Q2 2026, its #1238 holding.
  • Zions Bancorporation, National Association first reported a position in Corcept Therapeutics in Q1 2026 and has held it in 2 quarters since.
  • 113 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Zions Bancorporation, National Association's 13F filing for Q2 2026, filed 31 Jul 2026.